An Unbiased View of Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central nervous system, conolidine modulates alternate molecular targets. A Science Developments analyze identified that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR